In8bio Inc Stock Revenue
| INAB Stock | USD 0.30 0.01 3.23% |
In8bio Inc fundamentals help investors to digest information that contributes to In8bio's financial success or failures. It also enables traders to predict the movement of In8bio Stock. The fundamental analysis module provides a way to measure In8bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to In8bio stock.
| Last Reported | Projected for Next Year |
In8bio | Revenue |
In8bio Inc Company Revenue Analysis
In8bio's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Historical and Projected quarterly revenue of In8bio
Projected quarterly revenue analysis of In8bio Inc provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of In8bio match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in In8bio's stock price.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, In8bio Inc reported 0.0 of revenue. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The revenue for all United States stocks is 100.0% higher than that of the company.
In8bio Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses In8bio's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of In8bio could also be used in its relative valuation, which is a method of valuing In8bio by comparing valuation metrics of similar companies.In8bio is currently under evaluation in revenue category among its peers.
In8bio Institutional Holders
Institutional Holdings refers to the ownership stake in In8bio that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of In8bio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing In8bio's value.| Shares | Blackrock Inc | 2024-06-30 | 57.1 K | Rock Creek Group, Lp | 2024-06-30 | 52.4 K | Overbrook Management Corp | 2024-09-30 | 33.8 K | Northern Trust Corp | 2024-09-30 | 30 K | Lpl Financial Corp | 2024-09-30 | 12.3 K | Westside Investment Management, Inc. | 2024-06-30 | 12 K | Hrt Financial Llc | 2024-06-30 | 10.8 K | Hightower Advisors, Llc | 2024-06-30 | 10 K | Tower Research Capital Llc | 2024-06-30 | 3.8 K | Aigh Capital Management, Llc | 2024-09-30 | 1.7 M | Vanguard Group Inc | 2024-09-30 | 1.4 M |
In8bio Fundamentals
| Return On Equity | -1.8 | ||||
| Return On Asset | -0.78 | ||||
| Current Valuation | 22.94 M | ||||
| Shares Outstanding | 72.48 M | ||||
| Shares Owned By Insiders | 21.55 % | ||||
| Shares Owned By Institutions | 46.45 % | ||||
| Number Of Shares Shorted | 1.34 M | ||||
| Price To Book | 2.50 X | ||||
| EBITDA | (28.5 M) | ||||
| Net Income | (30.01 M) | ||||
| Cash And Equivalents | 25.74 M | ||||
| Cash Per Share | 1.37 X | ||||
| Total Debt | 4.89 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 9.08 X | ||||
| Book Value Per Share | 0.58 X | ||||
| Cash Flow From Operations | (23.34 M) | ||||
| Short Ratio | 0.51 X | ||||
| Earnings Per Share | (0.74) X | ||||
| Target Price | 4.75 | ||||
| Number Of Employees | 39 | ||||
| Beta | -0.069 | ||||
| Market Capitalization | 21.47 M | ||||
| Total Asset | 33.71 M | ||||
| Retained Earnings | (91.22 M) | ||||
| Working Capital | 19.23 M | ||||
| Net Asset | 33.71 M |
About In8bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze In8bio Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of In8bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of In8bio Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether In8bio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of In8bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of In8bio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on In8bio Inc Stock:Check out In8bio Piotroski F Score and In8bio Altman Z Score analysis. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of In8bio. If investors know In8bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about In8bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.74) | Return On Assets (0.78) | Return On Equity (1.80) |
The market value of In8bio Inc is measured differently than its book value, which is the value of In8bio that is recorded on the company's balance sheet. Investors also form their own opinion of In8bio's value that differs from its market value or its book value, called intrinsic value, which is In8bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because In8bio's market value can be influenced by many factors that don't directly affect In8bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between In8bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if In8bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, In8bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.